老年人肌少症的营养与药物干预:系统综述与网络荟萃分析
该系统综述与网络荟萃分析纳入59项RCT(N=5543),比较营养补充与药物对老年肌少症患者的影响。结果显示,蛋白联合维生素D及多种营养干预可能改善生活质量与握力,药物干预对握力、伸膝力量及计时起立行走测试无显著改善。
要点
- 蛋白联合维生素D可能改善握力(MD 2.07 kg,95%CI 0.91-3.23,中等确定性)。
- 多种营养干预可能改善握力(MD 2.32 kg,95%CI 0.85-3.79,低确定性)。
- 药物干预对握力、伸膝力量及计时起立行走测试无显著改善。
核心结论
- 中等确定性证据表明,蛋白联合维生素D补充及多种营养干预措施可能改善老年肌少症患者的生活质量、肌肉力量和肌肉量,药物治疗可能增加肌肉量。
研究设计与样本
- 系统综述与网络荟萃分析,检索Embase、MEDLINE、Cochrane CENTRAL、Web of Science和CINAHL至2022年4月,纳入59项RCT(N=5543),受试者为接受营养或药物干预的肌少症患者,采用随机效应网络荟萃分析和GRADE框架评估证据确定性。
主要发现
- 与常规护理相比,多种营养干预(SMD 0.65;95%CI 0.04-1.26)、蛋白(SMD 0.77;95%CI 0.38-1.17)和蛋白联合维生素D(SMD 0.37;95%CI 0.03-0.72)可能改善生活质量(中等确定性)。
- 蛋白联合维生素D可能增强握力(MD 2.07 kg;95%CI 0.91-3.23,中等确定性),多种营养干预可能改善握力(MD 2.32 kg;95%CI 0.85-3.79,低确定性)。
- 药物干预对握力(MD 1.72 kg;95%CI -0.74至4.18)、伸膝力量(SMD 0.49;95%CI -0.05至1.03)或计时起立行走测试(MD 0.06;95%CI -0.98至1.11)无显著改善。
临床怎么用
- 对老年肌少症患者,可考虑蛋白联合维生素D补充或多种营养干预以改善生活质量和握力,药物干预对功能测试的改善证据不足。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: This study aimed to compare the impacts of different nutritional supplements and drugs on older adults with sarcopenia. DESIGN: Systematic review and network meta-analysis. SETTING AND PARTICIPANTS: Participants with sarcopenia receiving nutritional and pharmacological interventions targeting sarcopenia in any setting. METHODS: We systematically searched electronic databases, including Embase, MEDLINE, the Cochrane Central Registry of Controlled Trials, Web of Science, and CINAHL up to April 2022. We included randomized controlled trials (RCTs) that examined the efficiency of nutritional and pharmacological interventions on patient-important outcomes in older adults with sarcopenia. We conducted frequent random-effects network meta-analyses to synthesize the evidence and used the Grading of Recommendations, Assessment, Development, and Evaluations (GRADE) framework to assess the certainty of the evidence. RESULTS: After screening 12,308 articles, we included 59 RCTs (N = 5543). Multinutrition [standardized mean difference (SMD), 0.65; 95% CI, 0.04-1.26], protein (SMD, 0.77; 95% CI, 0.38-1.17), and protein with vitamin D (SMD, 0.37; 95% CI, 0.03-0.72) probably improve the quality of life compared with usual care (moderate certainty). The combination of protein and vitamin D [mean difference (MD), 2.07 kg; 95% CI, 0.91-3.23] probably enhance handgrip strength (moderate certainty) and multinutrition (MD, 2.32 kg; 95% CI, 0.85-3.79) may improve handgrip strength (low certainty). However, the drug intervention does not yield significant improvements in handgrip strength (MD, 1.72 kg; 95% CI, -0.74 to 4.18), knee extension strength (SMD, 0.49; 95% CI: -0.05 to 1.03), or timed up and go tests (MD, 0.06; 95% CI, -0.98 to 1.11). CONCLUSIONS AND IMPLICATIONS: Moderate evidence indicating that the combination of protein and vitamin D supplements, along with multiple nutritional intervention measures, probably enhance the quality of life, muscle strength, and muscle mass in older individuals with sarcopenia. Pharmacological therapy may increase muscle mass.
引用
- Zhang M, Shen Y, Gao Y, et al. Nutritional and Pharmacological Interventions for Sarcopenia in Older Adults: A Systematic Review and Network Meta-Analysis. J Am Med Dir Assoc. 2026. PMID: 41422832. doi:10.1016/j.jamda.2025.106038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。